APO Research

APO RESEARCH · REPORT

Endostatin Protein

Selected research

Market Outlook & Growth Opportunities

Global Endostatin Protein Market Outlook and Growth Opportunities 2026

Market perspective

The global Endostatin Protein market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Endostatin Protein is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Endostatin Protein is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Endostatin Protein is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Endostatin Protein market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Endostatin Protein market include Hengrui Pharma, ZYBio, Sigma-Aldrich, R&D Systems, Prospec, PeproTech, Novus Biologicals, MyBioSource and MedChem Express, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Endostatin Protein market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Endostatin Protein and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Endostatin Protein sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Endostatin Protein market size, projected growth trends, production technologies, key applications, and end-use industries.

Endostatin Protein Segment by Company

Hengrui Pharma

ZYBio

Sigma-Aldrich

R&D Systems

Prospec

PeproTech

Novus Biologicals

MyBioSource

MedChem Express

Innovative Research

Denovo Biopharma

BioLegend

Endostatin Protein Segment by Type

Natural Endostatin

Recombinant Endostatin

Endostatin Protein Segment by Application

Medical

Pharmaceuticals

Endostatin Protein Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Endostatin Protein status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Endostatin Protein market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Endostatin Protein significant trends, drivers, influence factors in global and regions.

6. To analyze Endostatin Protein competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Endostatin Protein market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Endostatin Protein and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Endostatin Protein.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Endostatin Protein market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Endostatin Protein industry.

Chapter 3: Detailed analysis of Endostatin Protein manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Endostatin Protein in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Endostatin Protein in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Endostatin Protein Industry Trends Table 2. Endostatin Protein Industry Drivers Table 3. Endostatin Protein Industry Opportunities and Challenges Table 4. Endostatin Protein Industry Restraints Table 5. Global Endostatin Protein Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Endostatin Protein Revenue Share by Company (2021-2026) Table 7. Global Endostatin Protein Sales Volume by Company (kg) & (2021-2026) Table 8. Global Endostatin Protein Sales Volume Share by Company (2021-2026) Table 9. Global Endostatin Protein Average Price (US$/g) of Company (2021-2026) Table 10. Global Endostatin Protein Company Ranking, (2024-2026) & (USD Million) Table 11. Global Endostatin Protein Key Company Manufacturing Base & Headquarters Table 12. Global Endostatin Protein Company, Product Type & Application Table 13. Global Endostatin Protein Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Endostatin Protein by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Natural Endostatin Table 18. Significant Companies of Recombinant Endostatin Table 19. Global Endostatin Protein Sales Volume by Type 2021 VS 2025 VS 2032 (kg) Table 20. Global Endostatin Protein Sales Volume by Type (2021-2026) & (kg) Table 21. Global Endostatin Protein Sales Volume by Type (2027-2032) & (kg) Table 22. Global Endostatin Protein Sales Volume Share by Type (2021-2026) Table 23. Global Endostatin Protein Sales Volume Share by Type (2027-2032) Table 24. Global Endostatin Protein Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Endostatin Protein Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Endostatin Protein Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Endostatin Protein Sales Value Share by Type (2021-2026) Table 28. Global Endostatin Protein Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Medical Table 30. Significant Companies of Pharmaceuticals Table 31. Global Endostatin Protein Sales Volume by Application 2021 VS 2025 VS 2032 (kg) Table 32. Global Endostatin Protein Sales Volume by Application (2021-2026) & (kg) Table 33. Global Endostatin Protein Sales Volume by Application (2027-2032) & (kg) Table 34. Global Endostatin Protein Sales Volume Share by Application (2021-2026) Table 35. Global Endostatin Protein Sales Volume Share by Application (2027-2032) Table 36. Global Endostatin Protein Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Endostatin Protein Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Endostatin Protein Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Endostatin Protein Sales Value Share by Application (2021-2026) Table 40. Global Endostatin Protein Sales Value Share by Application (2027-2032) Table 41. Global Endostatin Protein Sales by Region: 2021 VS 2025 VS 2032 (kg) Table 42. Global Endostatin Protein Sales by Region (2021-2026) & (kg) Table 43. Global Endostatin Protein Sales Market Share by Region (2021-2026) Table 44. Global Endostatin Protein Sales by Region (2027-2032) & (kg) Table 45. Global Endostatin Protein Sales Market Share by Region (2027-2032) Table 46. Global Endostatin Protein Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Endostatin Protein Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Endostatin Protein Sales Value Share by Region (2021-2026) Table 49. Global Endostatin Protein Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Endostatin Protein Sales Value Share by Region (2027-2032) Table 51. Global Endostatin Protein Market Average Price (US$/g) by Region (2021-2026) Table 52. Global Endostatin Protein Market Average Price (US$/g) by Region (2027-2032) Table 53. Global Endostatin Protein Sales by Country: 2021 VS 2025 VS 2032 (kg) Table 54. Global Endostatin Protein Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Endostatin Protein Sales by Country (2021-2026) & (kg) Table 56. Global Endostatin Protein Sales Market Share by Country (2021-2026) Table 57. Global Endostatin Protein Sales by Country (2027-2032) & (kg) Table 58. Global Endostatin Protein Sales Market Share by Country (2027-2032) Table 59. Global Endostatin Protein Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Endostatin Protein Sales Value Market Share by Country (2021-2026) Table 61. Global Endostatin Protein Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Endostatin Protein Sales Value Market Share by Country (2027-2032) Table 63. Hengrui Pharma Company Information Table 64. Hengrui Pharma Business Overview Table 65. Hengrui Pharma Endostatin Protein Sales (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 66. Hengrui Pharma Endostatin Protein Product Portfolio Table 67. Hengrui Pharma Recent Development Table 68. ZYBio Company Information Table 69. ZYBio Business Overview Table 70. ZYBio Endostatin Protein Sales (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 71. ZYBio Endostatin Protein Product Portfolio Table 72. ZYBio Recent Development Table 73. Sigma-Aldrich Company Information Table 74. Sigma-Aldrich Business Overview Table 75. Sigma-Aldrich Endostatin Protein Sales (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 76. Sigma-Aldrich Endostatin Protein Product Portfolio Table 77. Sigma-Aldrich Recent Development Table 78. R&D Systems Company Information Table 79. R&D Systems Business Overview Table 80. R&D Systems Endostatin Protein Sales (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 81. R&D Systems Endostatin Protein Product Portfolio Table 82. R&D Systems Recent Development Table 83. Prospec Company Information Table 84. Prospec Business Overview Table 85. Prospec Endostatin Protein Sales (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 86. Prospec Endostatin Protein Product Portfolio Table 87. Prospec Recent Development Table 88. PeproTech Company Information Table 89. PeproTech Business Overview Table 90. PeproTech Endostatin Protein Sales (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 91. PeproTech Endostatin Protein Product Portfolio Table 92. PeproTech Recent Development Table 93. Novus Biologicals Company Information Table 94. Novus Biologicals Business Overview Table 95. Novus Biologicals Endostatin Protein Sales (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 96. Novus Biologicals Endostatin Protein Product Portfolio Table 97. Novus Biologicals Recent Development Table 98. MyBioSource Company Information Table 99. MyBioSource Business Overview Table 100. MyBioSource Endostatin Protein Sales (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 101. MyBioSource Endostatin Protein Product Portfolio Table 102. MyBioSource Recent Development Table 103. MedChem Express Company Information Table 104. MedChem Express Business Overview Table 105. MedChem Express Endostatin Protein Sales (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 106. MedChem Express Endostatin Protein Product Portfolio Table 107. MedChem Express Recent Development Table 108. Innovative Research Company Information Table 109. Innovative Research Business Overview Table 110. Innovative Research Endostatin Protein Sales (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 111. Innovative Research Endostatin Protein Product Portfolio Table 112. Innovative Research Recent Development Table 113. Denovo Biopharma Company Information Table 114. Denovo Biopharma Business Overview Table 115. Denovo Biopharma Endostatin Protein Sales (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 116. Denovo Biopharma Endostatin Protein Product Portfolio Table 117. Denovo Biopharma Recent Development Table 118. BioLegend Company Information Table 119. BioLegend Business Overview Table 120. BioLegend Endostatin Protein Sales (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 121. BioLegend Endostatin Protein Product Portfolio Table 122. BioLegend Recent Development Table 123. Key Raw Materials Table 124. Raw Materials Key Suppliers Table 125. Endostatin Protein Distributors List Table 126. Endostatin Protein Customers List Table 127. Research Programs/Design for This Report Table 128. Authors List of This Report Table 129. Secondary Sources Table 130. Primary Sources List of Figures Figure 1. Endostatin Protein Product Image Figure 2. Global Endostatin Protein Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Endostatin Protein Sales Value (2021-2032) & (US$ Million) Figure 4. Global Endostatin Protein Sales (2021-2032) & (kg) Figure 5. Global Endostatin Protein Sales Average Price (US$/g) & (2021-2032) Figure 6. Global Endostatin Protein Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Natural Endostatin Image Figure 10. Recombinant Endostatin Image Figure 11. Global Endostatin Protein Sales Volume by Type (2021 VS 2025 VS 2032) & (kg) Figure 12. Global Endostatin Protein Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Endostatin Protein Sales Volume Share by Type (2021-2032) Figure 14. Global Endostatin Protein Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Endostatin Protein Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Endostatin Protein Sales Value Share by Type (2021-2032) Figure 17. Medical Image Figure 18. Pharmaceuticals Image Figure 19. Global Endostatin Protein Sales Volume by Application (2021 VS 2025 VS 2032) & (kg) Figure 20. Global Endostatin Protein Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Endostatin Protein Sales Volume Share by Application (2021-2032) Figure 22. Global Endostatin Protein Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Endostatin Protein Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Endostatin Protein Sales Value Share by Application (2021-2032) Figure 25. Global Endostatin Protein Sales by Region: 2021 VS 2025 VS 2032 (kg) Figure 26. Global Endostatin Protein Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Endostatin Protein Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Endostatin Protein Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Endostatin Protein Sales Value (2021-2032) & (US$ Million) Figure 30. North America Endostatin Protein Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Endostatin Protein Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Endostatin Protein Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Endostatin Protein Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Endostatin Protein Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Endostatin Protein Sales Value (2021-2032) & (US$ Million) Figure 36. South America Endostatin Protein Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Endostatin Protein Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Endostatin Protein Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Endostatin Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Endostatin Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Endostatin Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Endostatin Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Endostatin Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Endostatin Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Endostatin Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Endostatin Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Endostatin Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Endostatin Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Endostatin Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Endostatin Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Endostatin Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Endostatin Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Endostatin Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Endostatin Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Endostatin Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Endostatin Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Endostatin Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Endostatin Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Endostatin Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Endostatin Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Endostatin Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Endostatin Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Endostatin Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Endostatin Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Endostatin Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Endostatin Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Endostatin Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Endostatin Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Endostatin Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Endostatin Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Endostatin Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Endostatin Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Endostatin Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Endostatin Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Endostatin Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Endostatin Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Endostatin Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Endostatin Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Endostatin Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Endostatin Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Endostatin Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Endostatin Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Endostatin Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Endostatin Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Endostatin Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Endostatin Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Endostatin Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Endostatin Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Endostatin Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Endostatin Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Endostatin Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Endostatin Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Endostatin Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Endostatin Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Endostatin Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Endostatin Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Endostatin Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Endostatin Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Endostatin Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Endostatin Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Endostatin Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Endostatin Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Endostatin Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Endostatin Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Endostatin Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Endostatin Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Endostatin Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Endostatin Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Endostatin Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Endostatin Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Endostatin Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Endostatin Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Endostatin Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Endostatin Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Endostatin Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Endostatin Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Endostatin Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Endostatin Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Endostatin Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Endostatin Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Endostatin Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Endostatin Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Endostatin Protein Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Endostatin Protein Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • Natural Endostatin
  • Recombinant Endostatin
Applications
  • Medical
  • Pharmaceuticals
Companies covered
  • Hengrui Pharma
  • ZYBio
  • Sigma-Aldrich
  • R&D Systems
  • Prospec
  • PeproTech
  • Novus Biologicals
  • MyBioSource
  • MedChem Express
  • Innovative Research
  • Denovo Biopharma
  • BioLegend

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Endostatin Protein Sales Value (2021-2032)
  4. 1.2.2 Global Endostatin Protein Sales Volume (2021-2032)
  5. 1.2.3 Global Endostatin Protein Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Endostatin Protein Market Dynamics
  1. 2.1 Endostatin Protein Industry Trends
  2. 2.2 Endostatin Protein Industry Drivers
  3. 2.3 Endostatin Protein Industry Opportunities and Challenges
  4. 2.4 Endostatin Protein Industry Restraints
3 Endostatin Protein Market by Company
  1. 3.1 Global Endostatin Protein Company Revenue Ranking in 2025
  2. 3.2 Global Endostatin Protein Revenue by Company (2021-2026)
  3. 3.3 Global Endostatin Protein Sales Volume by Company (2021-2026)
  4. 3.4 Global Endostatin Protein Average Price by Company (2021-2026)
  5. 3.5 Global Endostatin Protein Company Ranking (2024-2026)
  6. 3.6 Global Endostatin Protein Company Manufacturing Base and Headquarters
  7. 3.7 Global Endostatin Protein Company Product Type and Application
  8. 3.8 Global Endostatin Protein Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Endostatin Protein Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Endostatin Protein Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Endostatin Protein Market by Type
  1. 4.1 Endostatin Protein Type Introduction
  2. 4.1.1 Natural Endostatin
  3. 4.1.2 Recombinant Endostatin
  4. 4.2 Global Endostatin Protein Sales Volume by Type
  5. 4.2.1 Global Endostatin Protein Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Endostatin Protein Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Endostatin Protein Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Endostatin Protein Sales Value by Type
  9. 4.3.1 Global Endostatin Protein Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Endostatin Protein Sales Value by Type (2021-2032)
  11. 4.3.3 Global Endostatin Protein Sales Value Share by Type (2021-2032)
5 Endostatin Protein Market by Application
  1. 5.1 Endostatin Protein Application Introduction
  2. 5.1.1 Medical
  3. 5.1.2 Pharmaceuticals
  4. 5.2 Global Endostatin Protein Sales Volume by Application
  5. 5.2.1 Global Endostatin Protein Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Endostatin Protein Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Endostatin Protein Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Endostatin Protein Sales Value by Application
  9. 5.3.1 Global Endostatin Protein Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Endostatin Protein Sales Value by Application (2021-2032)
  11. 5.3.3 Global Endostatin Protein Sales Value Share by Application (2021-2032)
6 Endostatin Protein Regional Sales and Value Analysis
  1. 6.1 Global Endostatin Protein Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Endostatin Protein Sales by Region (2021-2032)
  3. 6.2.1 Global Endostatin Protein Sales by Region: 2021-2026
  4. 6.2.2 Global Endostatin Protein Sales by Region (2027-2032)
  5. 6.3 Global Endostatin Protein Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Endostatin Protein Sales Value by Region (2021-2032)
  7. 6.4.1 Global Endostatin Protein Sales Value by Region: 2021-2026
  8. 6.4.2 Global Endostatin Protein Sales Value by Region (2027-2032)
  9. 6.5 Global Endostatin Protein Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Endostatin Protein Sales Value (2021-2032)
  12. 6.6.2 North America Endostatin Protein Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Endostatin Protein Sales Value (2021-2032)
  15. 6.7.2 Europe Endostatin Protein Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Endostatin Protein Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Endostatin Protein Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Endostatin Protein Sales Value (2021-2032)
  21. 6.9.2 South America Endostatin Protein Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Endostatin Protein Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Endostatin Protein Sales Value Share by Country, 2025 VS 2032
7 Endostatin Protein Country-level Sales and Value Analysis
  1. 7.1 Global Endostatin Protein Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Endostatin Protein Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Endostatin Protein Sales by Country (2021-2032)
  4. 7.3.1 Global Endostatin Protein Sales by Country (2021-2026)
  5. 7.3.2 Global Endostatin Protein Sales by Country (2027-2032)
  6. 7.4 Global Endostatin Protein Sales Value by Country (2021-2032)
  7. 7.4.1 Global Endostatin Protein Sales Value by Country (2021-2026)
  8. 7.4.2 Global Endostatin Protein Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Endostatin Protein Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Endostatin Protein Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Endostatin Protein Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Endostatin Protein Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Endostatin Protein Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Endostatin Protein Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Endostatin Protein Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Endostatin Protein Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Endostatin Protein Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Endostatin Protein Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Endostatin Protein Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Endostatin Protein Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Endostatin Protein Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Endostatin Protein Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Endostatin Protein Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Endostatin Protein Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Endostatin Protein Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Endostatin Protein Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Endostatin Protein Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Endostatin Protein Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Endostatin Protein Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Endostatin Protein Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Endostatin Protein Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Endostatin Protein Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Endostatin Protein Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Endostatin Protein Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Endostatin Protein Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Endostatin Protein Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Endostatin Protein Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Endostatin Protein Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Endostatin Protein Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Endostatin Protein Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Endostatin Protein Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Endostatin Protein Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Endostatin Protein Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Endostatin Protein Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Endostatin Protein Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Endostatin Protein Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Endostatin Protein Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Endostatin Protein Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Endostatin Protein Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Endostatin Protein Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Endostatin Protein Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Endostatin Protein Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Endostatin Protein Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Endostatin Protein Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Endostatin Protein Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Endostatin Protein Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Endostatin Protein Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Endostatin Protein Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Endostatin Protein Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Endostatin Protein Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Endostatin Protein Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Endostatin Protein Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Endostatin Protein Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Endostatin Protein Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Endostatin Protein Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Endostatin Protein Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Endostatin Protein Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Endostatin Protein Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Endostatin Protein Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Endostatin Protein Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Endostatin Protein Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Endostatin Protein Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Endostatin Protein Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Endostatin Protein Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Endostatin Protein Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Endostatin Protein Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Endostatin Protein Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Endostatin Protein Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Endostatin Protein Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Endostatin Protein Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Endostatin Protein Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Endostatin Protein Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Endostatin Protein Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Endostatin Protein Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Endostatin Protein Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Endostatin Protein Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Endostatin Protein Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Endostatin Protein Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Endostatin Protein Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Endostatin Protein Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Endostatin Protein Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Endostatin Protein Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Hengrui Pharma
  2. 8.1.1 Hengrui Pharma Company Information
  3. 8.1.2 Hengrui Pharma Business Overview
  4. 8.1.3 Hengrui Pharma Endostatin Protein Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Hengrui Pharma Endostatin Protein Product Portfolio
  6. 8.1.5 Hengrui Pharma Recent Developments
  7. 8.2 ZYBio
  8. 8.2.1 ZYBio Company Information
  9. 8.2.2 ZYBio Business Overview
  10. 8.2.3 ZYBio Endostatin Protein Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 ZYBio Endostatin Protein Product Portfolio
  12. 8.2.5 ZYBio Recent Developments
  13. 8.3 Sigma-Aldrich
  14. 8.3.1 Sigma-Aldrich Company Information
  15. 8.3.2 Sigma-Aldrich Business Overview
  16. 8.3.3 Sigma-Aldrich Endostatin Protein Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Sigma-Aldrich Endostatin Protein Product Portfolio
  18. 8.3.5 Sigma-Aldrich Recent Developments
  19. 8.4 R&D Systems
  20. 8.4.1 R&D Systems Company Information
  21. 8.4.2 R&D Systems Business Overview
  22. 8.4.3 R&D Systems Endostatin Protein Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 R&D Systems Endostatin Protein Product Portfolio
  24. 8.4.5 R&D Systems Recent Developments
  25. 8.5 Prospec
  26. 8.5.1 Prospec Company Information
  27. 8.5.2 Prospec Business Overview
  28. 8.5.3 Prospec Endostatin Protein Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Prospec Endostatin Protein Product Portfolio
  30. 8.5.5 Prospec Recent Developments
  31. 8.6 PeproTech
  32. 8.6.1 PeproTech Company Information
  33. 8.6.2 PeproTech Business Overview
  34. 8.6.3 PeproTech Endostatin Protein Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 PeproTech Endostatin Protein Product Portfolio
  36. 8.6.5 PeproTech Recent Developments
  37. 8.7 Novus Biologicals
  38. 8.7.1 Novus Biologicals Company Information
  39. 8.7.2 Novus Biologicals Business Overview
  40. 8.7.3 Novus Biologicals Endostatin Protein Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Novus Biologicals Endostatin Protein Product Portfolio
  42. 8.7.5 Novus Biologicals Recent Developments
  43. 8.8 MyBioSource
  44. 8.8.1 MyBioSource Company Information
  45. 8.8.2 MyBioSource Business Overview
  46. 8.8.3 MyBioSource Endostatin Protein Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 MyBioSource Endostatin Protein Product Portfolio
  48. 8.8.5 MyBioSource Recent Developments
  49. 8.9 MedChem Express
  50. 8.9.1 MedChem Express Company Information
  51. 8.9.2 MedChem Express Business Overview
  52. 8.9.3 MedChem Express Endostatin Protein Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 MedChem Express Endostatin Protein Product Portfolio
  54. 8.9.5 MedChem Express Recent Developments
  55. 8.10 Innovative Research
  56. 8.10.1 Innovative Research Company Information
  57. 8.10.2 Innovative Research Business Overview
  58. 8.10.3 Innovative Research Endostatin Protein Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Innovative Research Endostatin Protein Product Portfolio
  60. 8.10.5 Innovative Research Recent Developments
  61. 8.11 Denovo Biopharma
  62. 8.11.1 Denovo Biopharma Company Information
  63. 8.11.2 Denovo Biopharma Business Overview
  64. 8.11.3 Denovo Biopharma Endostatin Protein Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Denovo Biopharma Endostatin Protein Product Portfolio
  66. 8.11.5 Denovo Biopharma Recent Developments
  67. 8.12 BioLegend
  68. 8.12.1 BioLegend Company Information
  69. 8.12.2 BioLegend Business Overview
  70. 8.12.3 BioLegend Endostatin Protein Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 BioLegend Endostatin Protein Product Portfolio
  72. 8.12.5 BioLegend Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Endostatin Protein Value Chain Analysis
  2. 9.1.1 Endostatin Protein Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Endostatin Protein Sales Mode & Process
  6. 9.2 Endostatin Protein Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Endostatin Protein Distributors
  9. 9.2.3 Endostatin Protein Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research